NIH Weekly Funding Opportunities and Policy Notices

Thursday, December 22, 2016 - 12:40am
Notice NOT-MH-17-011 from the NIH Guide for Grants and Contracts
Thursday, December 22, 2016 - 12:40am
Notice NOT-MH-17-010 from the NIH Guide for Grants and Contracts
Thursday, December 22, 2016 - 12:25am
Notice NOT-CA-17-012 from the NIH Guide for Grants and Contracts
Thursday, December 22, 2016 - 12:20am
Notice NOT-HD-16-041 from the NIH Guide for Grants and Contracts
Thursday, December 22, 2016 - 12:16am
Notice NOT-LM-17-003 from the NIH Guide for Grants and Contracts
Thursday, December 22, 2016 - 12:11am
Notice NOT-CA-17-011 from the NIH Guide for Grants and Contracts
Thursday, December 22, 2016 - 12:07am
Notice NOT-DA-17-060 from the NIH Guide for Grants and Contracts
Wednesday, December 21, 2016 - 10:20am
Notice NOT-OH-17-006 from the NIH Guide for Grants and Contracts
Wednesday, December 21, 2016 - 10:17am
Notice NOT-DA-17-007 from the NIH Guide for Grants and Contracts
Wednesday, December 21, 2016 - 10:06am
Funding Opportunity PAR-17-095 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support two types of cancer centers: 1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas: basic laboratory; clinical; and prevention, control and population-based research, and which have substantial transdisciplinary research that bridges these scientific areas; and 2) Cancer Centers, which are primarily focused on basic laboratory; clinical; and prevention, cancer control, and population-based research; or some combination of these areas. The purpose of both types of NCI-designated Cancer Centers is to capitalize on all institutional cancer research capabilities, integrating meritorious programs in laboratory, clinical, and population research into a single transdisciplinary research enterprise across all institutional boundaries. Cancer Centers supported through this FOA are expected to serve as major sources of discovery of the nature of cancer and of development of more effective approaches to prevention, diagnosis, and therapy; to contribute significantly to the development of shared resources that support research; to collaborate and coordinate their research efforts with other NCI-funded programs and investigators; and to disseminate research findings for the benefit of the community.
Wednesday, December 21, 2016 - 9:17am
Funding Opportunity PAR-17-094 from the NIH Guide for Grants and Contracts. The Maximizing Investigators' Research Award (MIRA) is a grant to provide support for the program of research in an investigator's laboratory that falls within the mission of NIGMS. For the purpose of this FOA, a program of research is the collection of projects in the investigator's lab that are relevant to the mission of NIGMS. The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding.
Wednesday, December 21, 2016 - 9:12am
Notice NOT-CA-17-009 from the NIH Guide for Grants and Contracts
Wednesday, December 21, 2016 - 8:57am
Notice NOT-CA-17-010 from the NIH Guide for Grants and Contracts
Wednesday, December 21, 2016 - 8:51am
Notice NOT-CA-17-008 from the NIH Guide for Grants and Contracts
Wednesday, December 21, 2016 - 8:41am
Notice NOT-CA-17-007 from the NIH Guide for Grants and Contracts
Wednesday, December 21, 2016 - 8:30am
Notice NOT-OD-17-028 from the NIH Guide for Grants and Contracts

Pages